Comparison of the efficacy of combined fluticasone propionate and olopatadine versus combined fluticasone propionate and fexofenadine for the treatment of allergic rhinoconjunctivitis induced by conjunctival allergen challenge
- 1 July 2002
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 24 (7) , 1161-1174
- https://doi.org/10.1016/s0149-2918(02)80027-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Evaluation of the efficacy of olapatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge modelClinical Therapeutics, 2001
- Treatment of UrticariaAmerican Journal of Clinical Dermatology, 2001
- Allergic Rhinoconjunctivitis – An OverviewActa Ophthalmologica Scandinavica, 2000
- Onset and duration of action of levocabastine nasal spray in atopic patients under nasal challenge conditionsJournal of Allergy and Clinical Immunology, 1999
- Evaluation of Olopatadine, a New Ophthalmic Antiallergic Agent with Dual Activity, Using the Conjunctival Allergen Challenge ModelAnnals of Allergy, Asthma & Immunology, 1998
- Efficacy and Safety of Fexofenadine Hydrochloride for Treatment of Seasonal Allergic RhinitisAnnals of Allergy, Asthma & Immunology, 1997
- Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challengeClinical and Experimental Allergy, 1994
- Intranasal steroids inhibit seasonal increases in ragweed-specific immunoglobulin IE antibodiesJournal of Allergy and Clinical Immunology, 1993
- Conjunctival Allergen ChallengeArchives of Ophthalmology (1950), 1990
- Antiallergic activity of H-receptor antagonists assessed by nasal challengeJournal of Allergy and Clinical Immunology, 1988